Nurix Therapeutics, Inc.
NRIX
$13.59
$0.403.03%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 609.58M | 448.05M | 443.14M | 243.99M | 287.91M |
| Total Receivables | 1.50M | 800.00K | 600.00K | 800.00K | 800.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.30M | 7.19M | 6.48M | 6.18M | 6.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 619.39M | 456.04M | 450.22M | 250.97M | 295.50M |
|
|
|||||
| Total Current Assets | 619.39M | 456.04M | 450.22M | 250.97M | 295.50M |
| Net Property, Plant & Equipment | 45.90M | 44.15M | 47.39M | 47.17M | 47.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.06M | 3.93M | 4.04M | 4.24M | 4.72M |
| Total Assets | 669.34M | 513.60M | 511.03M | 312.67M | 355.60M |
|
|
|||||
| Total Accounts Payable | 11.48M | 3.92M | 2.81M | 5.92M | 6.40M |
| Total Accrued Expenses | 34.48M | 26.26M | 21.55M | 27.16M | 24.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.01M | 6.55M | 7.93M | 7.31M | 7.49M |
| Total Finance Division Other Current Liabilities | 41.88M | 49.57M | 48.48M | 47.24M | 48.88M |
| Total Other Current Liabilities | 41.88M | 49.57M | 48.48M | 47.24M | 48.88M |
| Total Current Liabilities | 95.85M | 86.30M | 80.78M | 87.62M | 86.96M |
|
|
|||||
| Total Current Liabilities | 95.85M | 86.30M | 80.78M | 87.62M | 86.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.29M | 20.59M | 20.89M | 21.85M | 23.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.21M | 29.86M | 38.67M | 34.46M | 45.02M |
| Total Liabilities | 142.35M | 136.74M | 140.34M | 143.93M | 155.11M |
|
|
|||||
| Common Stock & APIC | 1.27B | 1.06B | 1.00B | 755.82M | 746.35M |
| Retained Earnings | -738.77M | -680.22M | -631.26M | -586.72M | -545.20M |
| Treasury Stock & Other | 150.00K | 344.00K | -135.00K | -350.00K | -655.00K |
| Total Common Equity | 526.99M | 376.86M | 370.69M | 168.75M | 200.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 526.99M | 376.86M | 370.69M | 168.75M | 200.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 526.99M | 376.86M | 370.69M | 168.75M | 200.49M |
|
|
|||||
